| Literature DB >> 29805272 |
Seon-Joo Park1, Ji-Hye Jung2, Sang-Woon Choi3,4, Hae-Jeung Lee1.
Abstract
The effect of high egg intake on metabolic syndrome (MetS), a major risk factor for cardiovascular disease (CVD), has not been clearly elucidated. This study was conducted to review the literature related to egg consumption and the risk of metabolic disease as well as to examine the association between high egg intake and MetS in Korean adults. A literature review was conducted using published papers in PubMed and EMBASE through December 2017. We have reviewed 26 articles, which were associated with egg consumption and metabolic diseases, and found that the results were controversial. Therefore, we analyzed data from 23,993 Korean adults aged 19 yrs and older. MetS was defined based on criteria from the Adult Treatment Panel III. Egg consumption of 4-6 times/wk and 1 time/day were significantly associated with reduced prevalence of MetS (Odds ratio (OR)=0.82; 95% Confidence interval (CI)=0.71-0.95 for 4-6 times/wk, OR=0.83; 95% CI=0.69-0.99 for 1 time/day) compared to those who consumed eggs less than once monthly. However, consuming two or more eggs per day was not associated with MetS. As for the components of MetS, an egg intake of once daily decreased the prevalence of abdominal obesity and an intake of 2-7 eggs weekly was shown to prevent a reduction in the high-density lipoprotein cholesterol levels. This study suggests that while consuming eggs 4-7 times weekly is associated with a lower prevalence of MetS, consuming two or more eggs daily is not associated with a reduced risk for MetS.Entities:
Keywords: Korean; egg consumption; metabolic syndrome
Year: 2018 PMID: 29805272 PMCID: PMC5960820 DOI: 10.5851/kosfa.2018.38.2.209
Source DB: PubMed Journal: Korean J Food Sci Anim Resour ISSN: 1225-8563 Impact factor: 2.622
The main findings of studies for egg intakes and metabolic diseases
| Author, year | Subjects | Country | Diseases/outcomes | Exposure category | Control or reference category | Result | Main findings |
|---|---|---|---|---|---|---|---|
| Cross-sectional study | |||||||
| 1,308 men, 1,541 women aged ≥20 y | China | T2D | ≥1 egg/d | <2 eggs/wk | N | The adjusted odds of T2D were 2.28 (95% CI, 1.14–4.54) for men, 3.01 (95% CI, 1.12-8.12) for women in ≥1 egg/day group compared with the <2 eggs/week group | |
| 1,262 subjects attending Canadian vascular prevention clinics | Canada | Plaque area | ≥3 egg/d | <2 eggs/wk | N | The patients consuming <2 eggs/week of plaque area was 125 mm2, versus 132 mm2 in those consuming ≥3 eggs/week | |
| 130,420 subjects aged 40-69 years | Korea | Metabolic syndrome | 7 eggs/wk | ≤1 egg/wk | P | 7 eggs/week group decreased the risk for MetS (OR, 0.77; 95% CI, 0.70-0.84) compared with ≤1 egg/week group in women | |
| Cohort study | |||||||
| 20,703 men, 36,295 women | USA | T2D | 7 eggs/wk | <1 egg/wk | N | The HRs of T2D was 1.58 (95% CI, 1.25–2.01) in men, and 1.77 (95% CI, 1.28–2.43) in women with 7 eggs/week group compared with the <1 egg/week group. | |
| 21,275 subjects | USA | Heart failure | ≥1 egg/d | <1 egg/wk | N | The incidences of HF significantly increased (HR, 1.64; 95% CI, 1.08–2.49) in ≥1 egg/day group compared with the <1 egg/week | |
| 21,327 subjects | USA | CVD and mortality | ≥7 eggs/wk | <1 egg/wk | N | The adjusted Hazard ratio for mortality was 1.23 (95% CI, 1.11-1.36) in ≥7 eggs per week group compared with the <1 egg/week | |
| 2,512 subjects aged 45-59 years | UK | CVD, T2D, stroke, mortality | ≥5 eggs/wk | Never or <1 egg/wk | N | The incidence of stroke increased with higher egg consumption among T2D and/or IGT sub-group (HR, 2.87; 95% CI, 1.13-7.27) | |
| 37,851 men aged 40-75 years, 80,082 women aged 34-59 years | USA | CHD | 1 egg/d | <1 egg /wk | N | The incidences of CHD significantly increased (HR, 2.02; 95% CI, 1.05-3.87 in men, HR, 1.49; 95% CI, 0.88-2.52 in women) in 1 egg/day group compared with the <1 egg/week among diabetic subjects | |
| 37,766 men, 32,805 women | Sweden | CVD | ≥1 egg/d | 0–3 eggs/mon | N | The incidences of CVD increased (HR, 1.99; 95% CI, 1.12-3.53 in men) in ≥1 egg/day group compared with the 0–3 egg /month group | |
| Cohort I (27,439 men, 27 073 women) Cohort II (31,750 men, 30,665 women) | Japan | CHD | Almost every day | <1 egg/wk | N | Adjusted HRs revealed significantly associated with CHD (HR, 2.17; 95% CI, 1.22-3.85) in almost daily egg intake group compared with the <1 egg/week | |
| 3,564 subjects | USA | T2D | ≥5 eggs/wk | <1 egg/mon | N/Null | Egg consumption was associated with T2D prevalence. Otherwise, prospective analysis did not show association of egg consumption and T2D incidence | |
| 36,910 men aged 45–79 years | Sweden | T2D | ≥5 egg/d | <1 egg/wk | Null | No significant differences in T2D incidence according to the egg intakes in prospective study | |
| 7,216 subjects aged 55–80 years | Spain | T2D | >4 eggs/d | <2 eggs/wk | Null | No significant differences in T2D incidence according to the egg intakes | |
| 3,898 subjects | USA | T2D | Almost daily eat egg | Never | Null | No significant intergroup differences in T2D incidence | |
| 1,429 subjects | USA | Carotid Atheros-clerosis | ≥2 eggs/d | Never or <1 egg/mon | Null | Low and moderate egg intake was inversely related to carotid atherosclerosis markers. No association showed in clinical vascular events. | |
| 27,248 men and 36,218 women aged 45–75 years | Japan | T2D | Highest egg intake | Lowest egg intake | Null | No significant intergroup differences in T2D incidence | |
| 65,364 women | France | T2D | ≥5 eggs/wk | non-consumer | Null | No association was showed between egg consumption and T2D risk. | |
| 9,734 subjects aged 25–74 years | USA | Ischemic stroke, CAD | ≥6 eggs/wk | <1 egg/wk | Null | Consumption of ≥6 eggs /week didn’t’ increase the stroke and ischemic stroke risk | |
| 14,185 subjects | Spain | CVD | ≥4 eggs/wk | Never or <1 egg/wk | Null | The association of egg consumption and the incidence of CVD was not found in the Mediterranean cohort. | |
| 2,332 men aged 42–60 years | Finland | T2D | >45 g egg/d | <14 g egg/d | P | The incidences of T2D decreased (HR, 0.62; 95% CI, 0.47-.0.82) in ≥45 g egg/day group compared with the<14 g egg/day group | |
| 2,887 subjects aged 40 years and over | Korea | Metabolic syndrome | ≥3 eggs/wk | Never | P | The adjusted HRs of MetS was 0.46 (95% CI, 0.26–0.82) in men, 0.54 (95% CI, 0.31 –0.93) in women in with ≥3 eggs/week group compared with the never eaten group | |
| Randomized Controlled Trial | |||||||
| 140 subjects | New Zealand | T2D | 2 eggs/d for 6 d/wk | <2 eggs/wk | Null | High egg consumption didn’t show any adverse effect on the lipid profile of T2D patients. | |
| 12 men, 25 women | USA | Metabolic syndrome | 3 eggs/d during 12 wk | Equivalent amount of egg substitute during 12 wk | P | The risk of MetS was significantly decreased in both groups. And NFκ-a, amyloid significantly decreased in egg intake group only | |
| 29 subjects aged 35-65 years | Mexico | T2D | 1 egg/d with 472 mL lactose-free milk during 5 wk | 40 g oatmeal with 472 mL lactose-free milk during 5 wk | P | AST(aspartate amino transferase) and TNF(Tumor necrosis factor)-alpha were significantly reduced during the egg consumption period | |
| 38 subjects(19 men, 19 women) aged 18-30 years | USA | Lipid profile | 1, 2, and 3 eggs/d for 4 wk each | - | P | Decreased DBP, LDL-C, LDL-C/HDL-C, increased HDL-C with egg intake. Plasma choline increased dose-dependently with egg intake | |
| 28 overweight men aged 40–70 years | USA | Inflamma-tory markers | 1 egg/d during 12 wk with CHO restriction diet | Placebo with CHO restriction diet | P | Plasma CRP decreased only in the egg treated group | |
CVD, cardiovascular disease; T2D, type 2 diabetes; IGT, impaired glucose tolerance; CHD, coronary heart disease; HF, heart failure; CHO, carbohydrate; OR, odds ratio; HR, hazard ratio; CI, confidence interval; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; CRP, C-reactive protein; P, positive result; N, negative result; Null, null result.
Characteristics of participants according to frequency of egg consumption in Korean adults aged 19 years and over
| Frequency of egg intake | ≤1/mon | >1/mon – <1/wk | 1/wk | 2-3/wk | 4-6/wk | 1/d | ≥2/d | ||
|---|---|---|---|---|---|---|---|---|---|
| (n=3,790) | (n=2,786) | (n=4,710) | (n=7,998) | (n=2,869) | (n=1,731) | (n=109) | |||
| Mean±SE | |||||||||
| Age (years) | 60.92 | 55.23 | 50.16 | 46.39 | 43.14 | 43.57 | 40.11 | <0.0001 | |
| Energy (kcal/d) | 1,664.1 | 1,802.1 | 1,904.3 | 1,982.1 | 1,992.1 | 2,016.2 | 1,895.9 | <0.0001 | |
| Vitamin C (mg/d) | 88.09 | 99.73 | 105.83 | 111.27 | 116.57 | 114.84 | 117.94 | <0.0001 | |
| Calcium intake (mg) | 413.35 | 457.85 | 488.42 | 518.21 | 528.13 | 554.15 | 526.46 | <0.0001 | |
| Body mass index (BMI, kg/m2) | 23.91 | 23.78 | 23.68 | 23.59 | 23.45 | 23.15 | 23.78 | <0.0001 | |
| Waist circumference (cm) | 83.10 | 82.40 | 81.57 | 80.90 | 79.89 | 79.09 | 80.85 | <0.0001[ | |
| SBP (mmHg) | 125.47 | 122.63 | 119.22 | 117.29 | 115.00 | 114.69 | 114.77 | <0.0001 | |
| DBP(mmHg) | 76.96 | 77.01 | 76.58 | 76.29 | 75.46 | 74.93 | 75.46 | <0.0001 | |
| Fasting blood glucose (mg/dL) | 101.61 | 100.26 | 98.37 | 96.75 | 94.10 | 95.01 | 95.42 | <0.0001 | |
| TG (mg/dL) | 143.74 | 139.32 | 131.38 | 130.63 | 117.97 | 121.34 | 122.89 | <0.0001 | |
| HDL-C (mg/dL) | 49.46 | 50.20 | 50.86 | 51.65 | 52.86 | 52.92 | 52.42 | <0.0001 | |
| Percent (%) | |||||||||
| Female | 64.22 | 58.94 | 55.88 | 57.10 | 63.02 | 61.06 | 55.05 | <0.001 | |
| Alcohol intake | Non-drinker | 23.03 | 17.73 | 14.61 | 11.12 | 10.63 | 9.88 | 11.93 | <0.001 |
| Less than once a month | 36.23 | 34.13 | 31.89 | 31.26 | 34.19 | 33.39 | 32.11 | ||
| Over once a month–less than heavy drinker | 31.90 | 38.87 | 42.21 | 45.42 | 43.36 | 42.81 | 39.45 | ||
| Heavy drinker[ | 7.89 | 8.44 | 10.30 | 11.19 | 11.08 | 12.54 | 15.6 | ||
| Smoking | Non-smoker | 62.80 | 60.88 | 58.13 | 58.41 | 63.02 | 59.16 | 59.63 | <0.001 |
| Past smoker | 12.51 | 12.17 | 13.82 | 11.33 | 10.32 | 12.42 | 7.34 | ||
| Current
smoker, | 9.68 | 9.26 | 10.23 | 11.97 | 10.53 | 11.61 | 17.43 | ||
| Current
smoker, | 6.83 | 8.04 | 8.39 | 8.85 | 7.63 | 8.78 | 10.09 | ||
| Physical activity | No exerciese | 46.02 | 47.60 | 47.15 | 46.19 | 46.46 | 44.89 | 38.53 | <0.001 |
| Regular walk | 30.05 | 30.44 | 27.64 | 29.31 | 29.38 | 28.54 | 28.44 | ||
| Regular moderate | 9.63 | 8.44 | 9.41 | 7.43 | 7.39 | 7.16 | 11.93 | ||
| Regular vigorous | 13.17 | 12.53 | 14.80 | 16.13 | 15.89 | 17.62 | 20.18 | ||
| Education | Elementary school | 57.84 | 43.29 | 27.30 | 17.69 | 10.98 | 9.59 | 9.17 | <0.001 |
| Middle school | 13.06 | 12.35 | 13.08 | 11.09 | 9.03 | 7.51 | 8.26 | ||
| High school | 17.07 | 21.57 | 27.45 | 32.38 | 32.69 | 33.97 | 39.45 | ||
| College or higher degree | 10.98 | 21.93 | 31.53 | 38.17 | 46.74 | 47.78 | 42.20 | ||
| Income | 1st (Lowest) | 31.00 | 26.53 | 22.29 | 21.38 | 22.20 | 20.85 | 27.52 | <0.001 |
| 2nd | 24.70 | 27.42 | 24.16 | 24.37 | 23.77 | 23.51 | 26.61 | ||
| 3rd | 22.40 | 24.41 | 25.50 | 26.21 | 24.89 | 25.82 | 20.18 | ||
| 4th (Highest) | 19.50 | 19.38 | 26.41 | 26.44 | 27.74 | 28.02 | 22.02 | ||
| Chronic disease
status[ | 26.09 | 21.11 | 15.37 | 11.84 | 7.98 | 9.24 | 11.01 | <0.0001 | |
| Survey year | 2007 | 11.74 | 11.02 | 10.04 | 9.20 | 9.59 | 12.54 | 14.68 | <0.0001 |
| 2008 | 24.72 | 22.83 | 23.78 | 22.63 | 22.45 | 20.45 | 22.94 | ||
| 2009 | 26.36 | 22.94 | 26.48 | 25.42 | 24.50 | 28.42 | 22.02 | ||
| 2010 | 17.99 | 20.46 | 20.23 | 21.78 | 20.77 | 19.76 | 13.76 | ||
| 2011 | 19.18 | 22.76 | 19.47 | 20.97 | 22.69 | 18.83 | 26.61 | ||
All data represent means±standard error or number (%) of participants.
** p-values were calculated with log transformation.
1) Heavy drinkers were those who consumed alcohol twice or more per week and had at least seven drinks per occasion (for men) or five drinks per occasion (for women).
2) Those who were diagnosed with or taking medicine for diseases such as diabetes, stroke, myocardial infarction, angina pectoris, chronic renal failure, and cancers.
SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.
The characteristics of participants according to metabolic syndrome status in Korean adults aged 19 years and over
| Characteristics | Metabolic
syndrome | Non-metabolic
syndrome | ||
|---|---|---|---|---|
| Mean±SE | ||||
| Age (yr) | 59.34±0.17 | 46.79±0.12 | <0.0001 | |
| Body mass index (BMI, kg/m2) | 26.1±0.04 | 22.84±0.02 | <0.0001 | |
| Energy (kcal/d) | 1,836.33±10.16 | 1,919±5.81 | <0.0001 | |
| Vitamin C (mg/d) | 100.85±1.16 | 107.81±0.71 | <0.0001 | |
| Egg consumption (servings/wk) | 1.76±0.03 | 2.38±0.02 | <0.0001 | |
| Calcium intake (mg) | 473.59±5.02 | 498.69±2.47 | <0.0001 | |
| Waist circumference (cm) | 89.86±0.11 | 78.56±0.07 | <0.0001 | |
| SBP (mmHg) | 131.13±0.22 | 115.26±0.12 | <0.0001 | |
| DBP (mmHg) | 81.16±0.14 | 74.79±0.07 | <0.0001 | |
| Fasting blood glucose (mg/dL) | 112.38±0.41 | 93.13±0.13 | <0.0001 | |
| TG (mg/dL) | 201.46±1.73 | 109.29±0.60 | <0.0001 | |
| HDL-C (mg/dL) | 43.53±0.14 | 53.68±0.09 | <0.0001 | |
| Percent (%) | ||||
| Female | 56.89 | 59.92 | <0.0001 | |
| Alcohol intake | Non-drinker | 20.52 | 12.32 | <0.0001 |
| Less than once a month | 33.31 | 32.91 | ||
| Once a month–less than heavy drinker | 34.14 | 43.77 | ||
| Heavy drinker[ | 11.00 | 10.05 | ||
| Smoking | Non-smoker | 57.55 | 60.72 | <0.0001 |
| Past smoker | 13.61 | 11.54 | ||
| Current, <1 pack per day | 8.75 | 11.43 | ||
| Current, ≥pack per day | 9.11 | 7.91 | ||
| Physical activity | Do not exercise/walk sometimes | 48.40 | 45.78 | <0.0001 |
| Regularly walk | 28.91 | 29.27 | ||
| Regular moderate-level activity | 8.70 | 8.14 | ||
| Regular vigorous-level activity | 13.03 | 15.74 | ||
| Education | Elementary school | 46.41 | 21.40 | <0.0001 |
| Middle school | 13.92 | 10.62 | ||
| High school | 21.91 | 29.85 | ||
| College or higher degree | 16.90 | 37.39 | ||
| Income | 1st (Lowest) | 25.18 | 23.31 | 0.0014 |
| 2nd | 25.32 | 24.39 | ||
| 3rd | 23.98 | 25.39 | ||
| 4th (Highest) | 23.53 | 25.17 | ||
| Chronic disease
status[ | 35.84 | 8.61 | ||
| Menopause | 46.05 | 22.27 | ||
| Survey year | 2007 | 11.40 | 9.94 | 0.0049 |
| 2008 | 21.97 | 23.37 | ||
| 2009 | 25.13 | 25.72 | ||
| 2010 | 20.25 | 20.48 | ||
| 2011 | 21.26 | 20.49 | ||
All data represent means±standard error or number (%) of participants.
Heavy drinkers were those who consumed alcohol twice or more per week and had at least seven drinks per occasion (for men) or five drinks per occasion (for women).
Those who were diagnosed with or taking medicine for diseases such as diabetes, stroke, myocardial infarction, angina pectoris, chronic renal failure, and cancers.
SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.
Odds ratio (OR) and 95% confidence interval (CI) for metabolic syndrome and individual components according to egg consumption frequency
| Metabolic syndrome | ||||
|---|---|---|---|---|
| Frequency | Number | Cases | Age, sex-adjusted OR | Multivariate[ |
| ≤1/mon | 3,790 | 1,369 | Reference | Reference |
| >1/mon - <1/wk | 2,786 | 852 | 0.98 (0.88-1.10) | 1.01 (0.89-1.14) |
| 1/wk | 4,710 | 1,178 | 0.94 (0.85-1.04) | 0.98 (0.87-1.09) |
| 2-3/wk | 7,998 | 1,666 | 0.89 (0.81-0.98) | 0.94 (0.84-1.04) |
| 4-6/wk | 2,869 | 464 | 0.76 (0.67-0.87) | 0.82 (0.71-0.95) |
| 1/d | 1,731 | 270 | 0.71 (0.60-0.82) | 0.83 (0.69-0.99) |
| ≥2/d | 109 | 19 | 0.97 (0.57-1.64) | 0.97 (0.55-1.72) |
| 0.171 | 0.439 | |||
| Abdominal obesity | ||||
| Frequency | Number | Cases | Age, sex-adjusted OR | Multivariate OR |
| ≤1/mon | 3,790 | 1,339 | Reference | Reference |
| >1/mon – <1/wk | 2,786 | 873 | 0.97 (0.88-1.08) | 1.01 (0.87-1.19) |
| 1/wk | 4,710 | 1,276 | 0.92 (0.83-1.01) | 0.92 (0.80-1.06) |
| 2-3/wk | 7,998 | 2,005 | 0.92 (0.85-1.01) | 0.96 (0.84-1.10) |
| 4-6/wk | 2,869 | 661 | 0.91 (0.81-1.02) | 1.03 (0.86-1.22) |
| 1/d | 1,731 | 330 | 0.70 (0.61-0.81) | 0.77 (0.63-0.96) |
| ≥2/d | 109 | 32 | 1.40 (0.91-2.15) | 1.56 (0.84-2.91) |
| 0.897 | 0.462 | |||
| High blood pressure | ||||
| Frequency | Number | Cases | Age, sex-adjusted OR | Multivariate OR |
| ≤1/mon | 3,790 | 2,121 | Reference | Reference |
| >1/mon – <1/wk | 2,786 | 1,379 | 1.04 (0.93-1.16) | 1.05 (0.94-1.18) |
| 1/wk | 4,710 | 1,918 | 0.94 (0.86-1.04) | 0.98 (0.89-1.09) |
| 2-3/wk | 7,998 | 2,819 | 0.94 (0.86-1.03) | 0.99 (0.90-1.09) |
| 4-6/wk | 2,869 | 824 | 0.86 (0.76-0.97) | 0.95 (0.84-1.08) |
| 1/d | 1,731 | 477 | 0.77 (0.67-0.88) | 0.88 (0.76-1.03) |
| ≥2/d | 109 | 28 | 0.84 (0.52-1.38) | 0.86 (0.52-1.43) |
| 0.114 | 0.354 | |||
| Hyperglyceridemia | ||||
| Frequency | Number | Cases | Age, sex-adjusted OR | Multivariate OR |
| ≤1/mon | 3,790 | 1,406 | Reference | Reference |
| >1/mon – <1/wk | 2,786 | 908 | 0.98 (0.88-1.09) | 0.99 (0.89-1.11) |
| 1/wk | 4,710 | 1,348 | 0.98 (0.89-1.08) | 0.98 (0.89-1.09) |
| 2-3/wk | 7,998 | 2,002 | 0.96 (0.88-1.05) | 0.97 (0.88-1.07) |
| 4-6/wk | 2,869 | 553 | 0.80 (0.70-0.90) | 0.82 (0.72-0.93) |
| 1/d | 1,731 | 347 | 0.81 (0.70-0.94) | 0.87 (0.75-1.02) |
| ≥2/d | 109 | 25 | 1.11 (0.69-1.79) | 1.12 (0.69-1.83) |
| 0.630 | 0.842 | |||
| Hypertriglyceridemia | ||||
| Frequency | Number | Cases | Age, sex-adjusted OR | Multivariate OR |
| ≤1/mon | 3,790 | 1,048 | Reference | Reference |
| >1/mon – <1/wk | 2,786 | 702 | 0.97 (0.86-1.09) | 0.98 (0.87-1.10) |
| 1/wk | 4,710 | 1,045 | 0.90 (0.82-1.00) | 0.94 (0.85-1.05) |
| 2-3/wk | 7,998 | 1,578 | 0.86 (0.78-0.94) | 0.89 (0.81-0.99) |
| 4-6/wk | 2,869 | 479 | 0.77 (0.68-0.88) | 0.83 (0.73-0.95) |
| 1/d | 1,731 | 298 | 0.79 (0.68-0.91) | 0.89 (0.76-1.04) |
| ≥2/d | 109 | 25 | 1.20 (0.76-1.91) | 1.22 (0.75-1.97) |
| p-value for trend | 0.686 | 0.915 | ||
| Low HDL- cholesterolemia | ||||
| Frequency | Number | Cases | Age, sex-adjusted OR | Multivariate OR |
| ≤1/mon | 3,790 | 1,769 | Reference | Reference |
| >1/mon – <1/wk | 2,786 | 1,119 | 0.89 (0.81-0.99) | 0.90 (0.81-1.00) |
| 1/wk | 4,710 | 1,680 | 0.84 (0.77-0.93) | 0.89 (0.79-1.02) |
| 2-3/wk | 7,998 | 2,674 | 0.82 (0.76-0.90) | 0.86 (0.79-0.95) |
| 4-6/wk | 2,869 | 891 | 0.76 (0.68-0.85) | 0.79 (0.71-0.89) |
| 1/d | 1,731 | 550 | 0.79 (0.70-0.90) | 0.83 (0.73-0.95) |
| ≥2/d | 109 | 35 | 0.91 (0.60-1.38) | 0.83 (0.54-1.29) |
| 0.080 | 0.078 | |||
1) Multivariate models were adjusted for age (continuous), sex (male or female), BMI (body mass index, continuous), energy intake (continuous), alcohol intake(non-drinker, less than once a month, over once a month-less than heavy drinker, and heavy drinkers), smoking (non-smoker, past smoker, current smoker (<1 pack per day), or current smoker (≥1 pack per day) smoker), physical activity (no exercise, regular walks, regular moderate activity, or regular vigorous activity), education (elementary school, middle school, high school, and college or higher degree), income (four categories on the basis of the equivalized income), chronic disease status (Those who were diagnosed with or taking medicine for diseases such as diabetes, stroke, myocardial infarction, angina pectoris, chronic renal failure, and cancers, yes or no) menopausal status (women only, yes or no), and survey year (2007, 2008, 2009, 2010, 2011).
HDL, high-density lipoprotein.